Observational studyUnited European gastroenterology journal2021

Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study.

Daniela Pugliese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.